KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoodRx Holdings (GDRX) Cash from Operations (2019 - 2025)

GoodRx Holdings' Cash from Operations history spans 7 years, with the latest figure at 32888000.0 for Q4 2025.

  • For Q4 2025, Cash from Operations fell 26.5% year-over-year to 32888000.0; the TTM value through Dec 2025 reached 167904000.0, down 8.69%, while the annual FY2025 figure was 167904000.0, 8.69% down from the prior year.
  • Cash from Operations for Q4 2025 was 32888000.0 at GoodRx Holdings, down from 76023000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 86862000.0 in Q3 2024 and bottomed at 9413000.0 in Q1 2025.
  • The 5-year median for Cash from Operations is 38756000.0 (2021), against an average of 40782350.0.
  • The largest YoY upside for Cash from Operations was 411.08% in 2025 against a maximum downside of 77.9% in 2025.
  • A 5-year view of Cash from Operations shows it stood at 49810000.0 in 2021, then tumbled by 36.0% to 31879000.0 in 2022, then tumbled by 50.22% to 15868000.0 in 2023, then surged by 181.97% to 44743000.0 in 2024, then dropped by 26.5% to 32888000.0 in 2025.
  • Per Business Quant, the three most recent readings for GDRX's Cash from Operations are 32888000.0 (Q4 2025), 76023000.0 (Q3 2025), and 49580000.0 (Q2 2025).